Shaked S, Rokach L, Arbel R, Razi T, Tadmor T. Glucagon-like peptide-1 receptor agonist exposure is associated with lower secondary malignancy risk during watch-and-wait in chronic lymphocytic leukemia: a timevarying analysis. Haematologica [Internet]. 2026Nov.12 [cited 2026Nov.14];. Available from: https://haematologica.org/article/view/14544